LCGC
BIIB icon

Legacy Capital Group California’s Biogen BIIB Stock Holding History

Legacy Capital Group California’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$532K Buy
+2,901
New +$535K 0.2% 165
2024
Q4 		– Sell
-1,798
Closed -$349K – 336
2024
Q3 		$349K Buy
1,798
+162
+10% +$33.9K 0.12% 203
2024
Q2 		$379K Buy
1,636
+595
+57% +$129K 0.14% 198
2024
Q1 		$224K Buy
1,041
+65
+7% +$15.2K 0.08% 281
2023
Q4 		$253K Buy
976
+110
+13% +$27K 0.1% 247
2023
Q3 		$223K Buy
866
+112
+15% +$30K 0.1% 252
2023
Q2 		$215K Buy
+754
New +$224K 0.09% 251

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Legacy Capital Group California's BIIB Position: Q1 2026 in Review

Legacy Capital Group California opened a new position in Biogen (BIIB) in Q1 2026: 2,901 shares worth $532K. The stake represents 0.2% of the portfolio and ranks #165 among its holdings. This is a return to the name: Legacy Capital Group California previously reported a position in BIIB as recently as Q3 2024.

Legacy Capital Group California first reported a position in BIIB in Q2 2023 and has held it in 7 quarters since. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Legacy Capital Group California held 2,901 shares of Biogen worth $532K as of Q1 2026.
  • Biogen was a new Legacy Capital Group California position in Q1 2026.
  • Biogen made up 0.2% of Legacy Capital Group California's portfolio in Q1 2026, its #165 holding.
  • Legacy Capital Group California first reported a position in Biogen in Q2 2023 and has held it in 7 quarters since.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.